Nutex Health Q2 revenue falls on absence of early-stage IDR process

Nutex Health

06/08/2026 21:48

Overview
US healthcare operator's Q2 revenue fell 14% yr/yr, missing analyst expectations
Company swung to net profit from loss, aided by lower contract services expenses
Total hospital division visits rose 9.6% yr/yr in Q2

Outlook
Company expects 25-30% reduction in normalized contract services expenses prospectively
Nutex Health plans to open three new hospitals later this yr
Company says future contract services expenses may differ significantly from current expectations

Result Drivers
CONTRACT SERVICES COSTS - Lower contract services expenses, due to a retroactive amendment to the HaloMD agreement and a reduced CMS administrative fee, drove improved profitability
IDR PROCESS IMPACT - Revenue declined as prior-year results benefited from early-stage improvement in the IDR process, which was not repeated in 2026
PATIENT VOLUME - Total hospital division visits increased 9.6% yr/yr in Q2, contributing to operational performance

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$210.75 mln
$215.03 mln (5 Analysts)
Q2 Gross Profit
 
$141.28 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Nutex Health Inc is $233.50, about 48.5% above its August 5 closing price of $157.26
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 6 three months ago

Reuters Recommended Reads
Aug 4 - Ardent Health Q2 hit by lower surgeries and admissions; cuts forecast
Aug 6 - Privia Health Q2 revenue beats estimates, outlook raised
Aug 5 - Clover Health Q2 revenue rises 56%, beating estimates on memership growth

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)